Published in Antibiot Khimioter on January 01, 2008
[Study of efficacy of modern fluoroquinolones against agent of glanders in experiments in vivo]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.79
[Chemotherapy for Bolivian hemorrhagic fever in experimentally infected guinea pigs]. Vopr Virusol (2009) 0.79
[In vitro and in vivo efficacy of Ingavirin against strains of pandemic influenza virus A(H1N1/09)v]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.79
[Effect of the antiviral drug Ingaviruin on intracellular transformations and import into the nucleus of influenza A virus nucleocapsid protein]. Vopr Virusol (2011) 0.78
[In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus]. Antibiot Khimioter (2010) 0.78
[Therapeutic efficacy of Ingavirin, a new domestic formulation against influenza A virus (H3N2)]. Antibiot Khimioter (2008) 0.78
[Tamsulosin administration for prophylaxis and treatment of stent-related symptoms]. Urologiia (2010) 0.78
[Combined treatment including ozonotherapy of patients with viral hepatitis ]. Vopr Kurortol Fizioter Lech Fiz Kult (2008) 0.77
[Effectiveness of virazol, realdiron and interferon inductors in experimental Omsk hemorrhagic fever]. Vopr Virusol (2003) 0.77
[Experimental study of Ingavirin antiviral activity against human adenovirus]. Antibiot Khimioter (2010) 0.77
[In vitro efficacy of ingavirin against the Mexican pandemic subtype H1N1 of influenza A virus, strains A/California/04/2009 and A/California/07/2009]. Antibiot Khimioter (2009) 0.77
[Experimental assessment of the possible significance of argasid ticks in preserving the natural foci of West Nile virus infection]. Med Parazitol (Mosk) (2013) 0.77
[Protective activity of Ingavirin in experimental lethal influenza due to pandemic influenza virus A (H1N1)v in albino mice]. Antibiot Khimioter (2010) 0.77
[Use of cyto-differentiating agents in oncology]. Vopr Onkol (2006) 0.77
[Antiviral activity of Ingavirin in experimental lethal influenza due to influenza virus B in albino mice]. Antibiot Khimioter (2010) 0.77
[Isolation and identification of Crimean-Congo hemorrhagic fever virus in the Stavropol territory]. Zh Mikrobiol Epidemiol Immunobiol (2002) 0.77
[Toxicity estimation of unspecific medicinal antiviral agents for prophylaxis and therapy of hazard and especially hazard viral infections]. Antibiot Khimioter (2009) 0.77
[In vitro investigation of the antiviral activity of Ingavirin against human metapneumovirus]. Vopr Virusol (2012) 0.77
[Ribavirin prophylaxis and therapy of experimental West Nile fever]. Antibiot Khimioter (2009) 0.77
[In vitro and in vivo effects of ingavirin on the ultrastructure and infectivity of influenza virus]. Vopr Virusol (2011) 0.77
[Using reverse genetics method for developing recombinant strains of influenza viruses acceptable for use as live attenuated vaccines]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.76
[Design of equine serum-based Marburg virus immunoglobulin]. Vopr Virusol (2008) 0.76
[Temperate Legionella bacteriophage: discovery and characteristics]. Zh Mikrobiol Epidemiol Immunobiol (2008) 0.76
[Use of guinea pigs for assessing the efficacy of vaccines against Lassa fever]. Vopr Virusol (2004) 0.76
[Hemorrhagic (Marburg, Ebola, Lassa, and Bolivian) fevers: epidemiology, clinical pictures, and treatment]. Vopr Virusol (2006) 0.76
[Experimental investigation of Ingavirin antiviral activity against human parainfluenza virus]. Antibiot Khimioter (2010) 0.76
[EPIDEMIOLOGIC ANALYSIS OF OUTBREAKS OF DISEASES CAUSED BY AMERICAN EQUINE ENCEPHALITIS CAUSATIVE AGENTS IN ENDEMIC REGIONS]. Zh Mikrobiol Epidemiol Immunobiol (2016) 0.76
[Antiviral effect of Ingavirin against seasonal influenza virus A/H1N1 in MDCK cell culture]. Antibiot Khimioter (2009) 0.75
[Prophylactic and therapeutic efficacies of Ingavirin, a novel Russian chemotherapeutic, with respect to influenza pathogen A (H5N1)]. Antibiot Khimioter (2010) 0.75
Development of monoclonal antibodies to highly pathogenic avian influenza H5N1 virus and their application to diagnostics, prophylaxis, and therapy. Acta Virol (2011) 0.75
[Diagnostic value of determining ceruloplasmin and transferrin in various acute and chronic liver diseases]. Ter Arkh (1982) 0.75
[Pelvic lymphadenectomy in prostatic cancer]. Urologiia (2010) 0.75
[In vitro activity of Ingavirin against influenza virus A (H3N2)]. Antibiot Khimioter (2009) 0.75
Structural organization of the genome of SARS-associated coronavirus (Strain SoD) isolated on the territory of the Russian Federation. Bull Exp Biol Med (2004) 0.75
[Production and study of hybridomas, producing monoclonal antibodies to the structural glycoprotein of Marburg virus]. Vopr Virusol (2002) 0.75
[Clinical efficacy and safety of the drug "Likoprofit potential-formula"]. Urologiia (2010) 0.75
[Laser irradiation of venous blood for prevention of reperfusion syndrome in myocardial infarction]. Patol Fiziol Eksp Ter (1993) 0.75
[Current outlook on screening of prostatic cancer]. Urologiia (2010) 0.75
[Minimally invasive method of the treatment of prostatic abscess]. Urologiia (2003) 0.75
[Center of special laboratory diagnostics and treatment of dangerous and exotic infectious diseases in the system of the antiepidemic protection of the territory of the Russian Federation]. Zh Mikrobiol Epidemiol Immunobiol (2002) 0.75
[Changes in protein metabolism in prolonged hypokinesia]. Voen Med Zh (1978) 0.75
[In vitro Ingavirin efficacy against adenoviral infection pathogen]. Antibiot Khimioter (2009) 0.75
[Viruses and glomerulonephritis]. Voen Med Zh (2002) 0.75
[Severe forms of myocardial lesions of noncoronarogenic and nonrheumatic nature]. Klin Med (Mosk) (1977) 0.75
[Biological effect of laser radiation on the functional state of cardiomyocytes]. Patol Fiziol Eksp Ter (1993) 0.75
[Improvement of surgical outcomes in patients with prostatic adenoma due to postoperative administration of the drug likoprofit]. Urologiia (2009) 0.75
[Oral vaccination against smallpox (on the return of smallpox vaccination)]. Vestn Ross Akad Med Nauk (2003) 0.75
[Functional state of the cardiovascular system in prolonged exposure to low-value acceleration]. Voen Med Zh (1978) 0.75
[Differential diagnosis of painful forms of myocarditis and cardiac ischemia]. Klin Med (Mosk) (1969) 0.75
[A case of malignant paraganglioma]. Klin Med (Mosk) (1968) 0.75
[Optimisation of early diagnosis of prostatic diseases in megapolis setting]. Urologiia (2010) 0.75
[Non-coronarogenic diseases of the myocardium. Clinicopathogenetic aspects]. Kardiologiia (1982) 0.75
[Acute glomerulonephritis complicated by acute obstructive pyelonephritis]. Urologiia (2010) 0.75
[Value of a method of determining the hourly secretion of liver bile]. Vrach Delo (1977) 0.75
[Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia]. Urologiia (2001) 0.75
[In vitro investigation of Ingavirin efficacy against influenza B virus]. Antibiot Khimioter (2009) 0.75
[Interferon inductor cupping of postvaccinal complications after variolation]. Antibiot Khimioter (2010) 0.75
[Experience in the use of tetracycline combined with glucosamine in the therapy of cholecystitis]. Sov Med (1968) 0.75
[Improved skeletal traction in fractures of the leg bones]. Ortop Travmatol Protez (1981) 0.75
[A cytogenetic study of hematopoietic cells in fish from the reservoirs of the Noril'sk-Pyasina water system (Taimyr)]. Izv Akad Nauk Ser Biol (1996) 0.75
[Porphyrin disease]. Klin Med (Mosk) (1971) 0.75
[Pseudoacute abdomen in patients with influenza pneumonia]. Klin Med (Mosk) (1971) 0.75
[Isolation and identification of the smallpox virus which caused iatrogenic vaccinia in children in the city of Vladivostok]. Zh Mikrobiol Epidemiol Immunobiol (2001) 0.75
[On the use of cholisorb on the hepatic exocrine function in patients after cholecystectomy]. Eksp Klin Farmakol (1997) 0.75
[Clinical immunological observations of persons in a period of prolonged hypokinesia and the readaptation thereafter]. Kosm Biol Aviakosm Med (1978) 0.75
[Tamsulosin in combind treatment of patients with urolithiasis]. Urologiia (2009) 0.75
[Antiviral activity of an interferon inducer amixin in experimental West Nile Fever]. Vopr Virusol (2004) 0.75
[Cholecystectomy: its necessity and the principles of rehabilitative treatment]. Vopr Kurortol Fizioter Lech Fiz Kult (2001) 0.75
[Prognosis of readaptive disorders occurring after prolonged hypokinesia]. Voen Med Zh (1978) 0.75
[Effect of physical factors on microcirculation in the stomach and duodenal mucosa in gastroduodenal pathology]. Vopr Kurortol Fizioter Lech Fiz Kult (2001) 0.75
[Clinical variants of Takayasu syndrome]. Klin Med (Mosk) (1969) 0.75
[Isolation and identification of the infective agent of severe acute respiratory syndrome (SARS) from a patient with atypical pneumonia]. Zh Mikrobiol Epidemiol Immunobiol (2003) 0.75
[Narrowband fibrocystoscopy in diagnosis of bladder cancer]. Urologiia (2010) 0.75
[Intercavitary electrical stimulation of the gastrointestinal tract and mucosa with a stand-alone electric stimulator in the treatment of patients in the physicochemical stage of gallbladder disease]. Eksp Klin Gastroenterol (2003) 0.75
[The use of monoclonal antibodies in studying the causative agents of viral hemorrhagic fevers]. Vopr Virusol (2003) 0.75
[Differential diagnosis of primary rheumocarditis and infectious-allergic (nonspecific) myocarditis]. Vopr Revm (1970) 0.75
[Efficacy of amixine in experimental hantavirus infection]. Vopr Virusol (2003) 0.75
[Tracheobronchoscopy and puncture of bifurcated lymph nodes in patients with cancer of the esophagus]. Grudn Khir (1977) 0.75
[Use of tetracycline in combination with glucosamine in inflammatory processes of biliary tract]. Antibiotiki (1967) 0.75
[Duodenal intubation: present view (on the occasion of the 100th anniversary of duodenal intubation)]. Ter Arkh (2010) 0.75